BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 32543669)

  • 1. International prescribing patterns and polypharmacy in older people with advanced chronic kidney disease: results from the European Quality study.
    Hayward S; Hole B; Denholm R; Duncan P; Morris JE; Fraser SDS; Payne RA; Roderick P; Chesnaye NC; Wanner C; Drechsler C; Postorino M; Porto G; Szymczak M; Evans M; Dekker FW; Jager KJ; Caskey FJ;
    Nephrol Dial Transplant; 2021 Feb; 36(3):503-511. PubMed ID: 32543669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polypharmacy and potentially inappropriate prescribing of benzodiazepines in older nursing home residents.
    Kummer I; Reissigová J; Lukačišinová A; Ortner Hadžiabdić M; Stuhec M; Liperoti R; Finne-Soveri H; Onder G; van Hout H; Fialová D
    Ann Med; 2024 Dec; 56(1):2357232. PubMed ID: 38833339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Any versus long-term prescribing of high risk medications in older people using 2012 Beers Criteria: results from three cross-sectional samples of primary care records for 2003/4, 2007/8 and 2011/12.
    Ble A; Masoli JA; Barry HE; Winder RE; Tavakoly B; Henley WE; Kuchel GA; Valderas JM; Melzer D; Richards SH
    BMC Geriatr; 2015 Nov; 15():146. PubMed ID: 26542116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polytherapy and the risk of potentially inappropriate prescriptions (PIPs) among elderly and very elderly patients in three different settings (hospital, community, long-term care facilities) of the Friuli Venezia Giulia region, Italy: are the very elderly at higher risk of PIPs?
    Cojutti P; Arnoldo L; Cattani G; Brusaferro S; Pea F
    Pharmacoepidemiol Drug Saf; 2016 Sep; 25(9):1070-8. PubMed ID: 27184012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polypharmacy is a risk factor for mortality, severe chronic kidney disease, and liver disease among privately insured adults with cerebral palsy.
    Whitney DG; Schmidt M; Haapala H
    J Manag Care Spec Pharm; 2021 Jan; 27(1):51-63. PubMed ID: 33377441
    [No Abstract]   [Full Text] [Related]  

  • 6. Inter-practice variation in polypharmacy prevalence amongst older patients in primary care.
    Sinnige J; Braspenning JC; Schellevis FG; Hek K; Stirbu I; Westert GP; Korevaar JC
    Pharmacoepidemiol Drug Saf; 2016 Sep; 25(9):1033-41. PubMed ID: 27133740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescribing patterns and predictors of high-level polypharmacy in the elderly population: A prospective surveillance study from two teaching hospitals in India.
    Harugeri A; Joseph J; Parthasarathi G; Ramesh M; Guido S
    Am J Geriatr Pharmacother; 2010 Jun; 8(3):271-80. PubMed ID: 20624616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentially inappropriate prescribing in older adults with advanced chronic kidney disease.
    Molnar AO; Bota S; Jeyakumar N; McArthur E; Battistella M; Garg AX; Sood MM; Brimble KS
    PLoS One; 2020; 15(8):e0237868. PubMed ID: 32818951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal Trends in Polypharmacy and Hyperpolypharmacy in Older New Zealanders over a 9-Year Period: 2005–2013.
    Nishtala PS; Salahudeen MS
    Gerontology; 2015; 61(3):195-202. PubMed ID: 25428287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Deprescribing in Older Adults with Chronic Kidney Disease.
    Triantafylidis LK; Hawley CE; Perry LP; Paik JM
    Drugs Aging; 2018 Nov; 35(11):973-984. PubMed ID: 30284120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kidney Function, Polypharmacy, and Potentially Inappropriate Medication Use in a Community-Based Cohort of Older Adults.
    Secora A; Alexander GC; Ballew SH; Coresh J; Grams ME
    Drugs Aging; 2018 Aug; 35(8):735-750. PubMed ID: 30039344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between polypharmacy and health-related quality of life among non-dialysis chronic kidney disease patients.
    Adjeroh L; Brothers T; Shawwa K; Ikram M; Al-Mamun MA
    PLoS One; 2023; 18(11):e0293912. PubMed ID: 37956162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Features of anticholinergic prescriptions and predictors of high use in the elderly: Population-based study.
    Joung KI; Shin JY; Cho SI
    Pharmacoepidemiol Drug Saf; 2019 Dec; 28(12):1591-1600. PubMed ID: 31692168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterizing Potentially Inappropriate Prescribing of Proton Pump Inhibitors in Older People in Primary Care in Ireland from 1997 to 2012.
    Moriarty F; Bennett K; Cahir C; Fahey T
    J Am Geriatr Soc; 2016 Dec; 64(12):e291-e296. PubMed ID: 27996115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of potentially inappropriate prescribing in a subpopulation of older European clinical trial participants: a cross-sectional study.
    O Riordan D; Aubert CE; Walsh KA; Van Dorland A; Rodondi N; Du Puy RS; Poortvliet RKE; Gussekloo J; Sinnott C; Byrne S; Galvin R; Jukema JW; Mooijaart SP; Baumgartner C; McCarthy V; Walsh EK; Collet TH; Dekkers OM; Blum MR; Kearney PM
    BMJ Open; 2018 Mar; 8(3):e019003. PubMed ID: 29567842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Drug Prescribing for Patients with Chronic Kidney Disease in General Practice: a Cross-Sectional Study].
    Mahner M; Raus C; Ludwig F; Weckmann G; Stracke S; Chenot JF
    Dtsch Med Wochenschr; 2018 Jun; 143(12):e99-e107. PubMed ID: 29898484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How do potentially inappropriate medications and polypharmacy affect mortality in frail and non-frail cognitively impaired older adults? A cohort study.
    Porter B; Arthur A; Savva GM
    BMJ Open; 2019 May; 9(5):e026171. PubMed ID: 31092652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prescribing quality in secondary care patients with different stages of chronic kidney disease: a retrospective study in the Netherlands.
    Smits KP; Sidorenkov G; van Ittersum FJ; Waanders F; Bilo HJ; Navis GJ; Denig P
    BMJ Open; 2019 Jul; 9(7):e025784. PubMed ID: 31326925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of hyperpolypharmacy and potentially inappropriate medications (PIMs) on functional decline in older patients discharged from acute care hospitals.
    Fabbietti P; Ruggiero C; Sganga F; Fusco S; Mammarella F; Barbini N; Cassetta L; Onder G; Corsonello A; Lattanzio F; Di Rosa M
    Arch Gerontol Geriatr; 2018; 77():158-162. PubMed ID: 29778885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of Polypharmacy, Hyperpolypharmacy and Potentially Inappropriate Medication Use in Older Adults in India: A Systematic Review and Meta-Analysis.
    Bhagavathula AS; Vidyasagar K; Chhabra M; Rashid M; Sharma R; Bandari DK; Fialova D
    Front Pharmacol; 2021; 12():685518. PubMed ID: 34093207
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.